Advertisement
Screener

QUIDELORTHO CORP (QDEL) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

QUIDELORTHO CORP Cash Flow Breakdown

Cash flow breakdown shows where QUIDELORTHO CORP's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-28: from running the business, $105.20M came in.
  • Fiscal year ended 2025-12-28: from investing, $192.70M went out.
  • Fiscal year ended 2025-12-28: from financing, $155.80M came in.
  • Fiscal year ended 2025-12-28: change in cash, $71.30M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backCommercial paperStaff share taxNew shares soldNot split outChange in cash
2025-12-28$105.20M-$192.70M$0.00-$2.29B$3.00M-$5.40M$6.10M$2.44B*$71.30M
2024-12-29$83.00M-$149.90M$0.00-$143.00M-$1.60M-$9.60M$5.00M$198.00M*-$21.00M
2023-12-31$280.20M-$187.60M-$7.20M-$228.00M$1.60M-$13.50M$11.60M-$30.30M*-$174.40M
2023-01-01$885.30M-$1.64B-$74.30M$0.00-$8.60M$26.40M$308.50M*-$508.90M
2022-01-02$805.90M-$319.50M-$103.50M$0.00-$37.10M$7.60M-$40.10M*$312.90M
2021-01-03$629.70M-$63.30M-$43.70M-$4.30M$9.60M-$91.90M*$437.10M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backCommercial paperStaff share taxNew shares soldNot split outChange in cash
2026-06-28-$110.60M*-$107.30M*-$19.60M*$700.00K*-$900.00K*$400.00K*$220.00M*
2026-03-29-$33.00M-$34.00M-$22.40M-$1.70M-$1.10M$1.80M$61.00M*-$29.40M
2025-12-28$131.90M*-$49.60M*-$1.60M*-$2.30M*-$400.00K*$100.00K*-$6.90M*
2025-09-28-$45.50M*-$53.90M*-$2.22B*$3.40M*-$900.00K*$2.90M*$2.26B*
2025-06-29-$46.80M*-$33.00M*-$36.00M*$1.90M*-$2.70M*$100.00K*$140.00M*
2025-03-30$65.60M-$56.20M-$36.00M$0.00-$1.40M$3.00M$52.00M*$28.70M
2024-12-29$63.70M*-$37.90M*-$36.00M*$0.00*-$900.00K*$0.00*-$32.00M*
2024-09-29$117.90M*-$56.50M*-$3.30M*$0.00*-$400.00K*$400.00K*-$23.00M*
2024-06-30-$97.90M*-$35.30M*-$51.80M*-$300.00K*-$2.50M*$4.10M*$213.00M*
2024-03-31-$700.00K-$20.20M-$51.90M-$1.30M-$5.80M$500.00K$40.00M*-$40.50M
2023-12-31$80.40M*-$55.10M*-$7.20M*-$52.30M*-$1.30M*-$500.00K*$3.50M*
2023-10-01$41.50M*-$21.30M*-$51.90M*$2.90M*-$500.00K*$800.00K*
2023-07-02-$30.60M*-$42.30M*-$71.90M*$0.00*-$3.00M*$5.50M*-$30.30M*
2023-04-02$188.90M-$68.90M-$51.90M$0.00-$9.50M$1.80M$61.00M
2023-01-01$169.40M*-$59.30M*$0.00*$0.00*-$600.00K*$21.20M*-$52.30M*
2022-10-02-$9.70M*-$29.80M*-$74.30M*-$500.00K*$800.00K*-$52.00M*
2022-07-03$224.70M*-$1.53B*-$700.00K*$900.00K*$412.90M*
2022-04-03$500.90M-$24.70M-$6.80M$3.50M$472.70M
2022-01-02$321.40M*-$96.00M*$0.00*-$1.10M*$300.00K*
2021-10-03$77.00M*-$93.20M*-$100.00K*-$600.00K*$2.40M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92